en
Scientific article
Open access
English

The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinson's disease with a sexual dimorphism

Published inJournal of neurology, neurosurgery and psychiatry, vol. 84, no. 6, p. 666-673
Publication date2013
Abstract

The catechol-O-methyltranferase (COMT) is one of the main enzymes that metabolise dopamine in the brain. The Val158Met polymorphism in the COMT gene (rs4680) causes a trimodal distribution of high (Val/Val), intermediate (Val/Met) and low (Met/Met) enzyme activity. We tested whether the Val158Met polymorphism is a modifier of the age at onset (AAO) in Parkinson's disease (PD). The rs4680 was genotyped in a total of 16 609 subjects from five independent cohorts of European and North American origin (5886 patients with PD and 10 723 healthy controls). The multivariate analysis for comparing PD and control groups was based on a stepwise logistic regression, with gender, age and cohort origin included in the initial model. The multivariate analysis of the AAO was a mixed linear model, with COMT genotype and gender considered as fixed effects and cohort and cohort-gender interaction as random effects. COMT genotype was coded as a quantitative variable, assuming a codominant genetic effect. The distribution of the COMT polymorphism was not significantly different in patients and controls (p=0.22). The Val allele had a significant effect on the AAO with a younger AAO in patients with the Val/Val (57.1±13.9, p=0.03) than the Val/Met (57.4±13.9) and the Met/Met genotypes (58.3±13.5). The difference was greater in men (1.9 years between Val/Val and Met/Met, p=0.007) than in women (0.2 years, p=0.81). Thus, the Val158Met COMT polymorphism is not associated with PD in the Caucasian population but acts as a modifier of the AAO in PD with a sexual dimorphism: the Val allele is associated with a younger AAO in men with idiopathic PD.

Keywords
  • Age of Onset
  • Aged
  • Catechol O-Methyltransferase/genetics
  • Genotype
  • Humans
  • Male
  • Middle Aged
  • Parkinson Disease/genetics
  • Polymorphism, Single Nucleotide/genetics
  • Sex Factors
Citation (ISO format)
KLEBE, Stephan et al. The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinson’s disease with a sexual dimorphism. In: Journal of neurology, neurosurgery and psychiatry, 2013, vol. 84, n° 6, p. 666–673. doi: 10.1136/jnnp-2012-304475
Main files (1)
Article (Published version)
accessLevelPublic
Identifiers
ISSN of the journal0022-3050
627views
1574downloads

Technical informations

Creation01/03/2014 1:44:00 PM
First validation01/03/2014 1:44:00 PM
Update time03/14/2023 8:53:26 PM
Status update03/14/2023 8:53:25 PM
Last indexation01/16/2024 1:59:36 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack